Skip to main content
Premium Trial:

Request an Annual Quote

Celera Adds GeneFormatics Protein Database to Discovery System

SAN FRANCISCO, Oct. 29 – Celera Genomics will include GeneFormatics’ structural proteomics database in its Discovery System, the companies announced Monday.

San Diego, Calif.-based GeneFormatics’ Proteomics Database contains approximately 7,000 novel biochemical function and structure assignments for potential drug targets in humans, according to the company.

Financial details of the agreement were not disclosed.

“Knowledge of the biochemical function and structures of encoded proteins are critical to leveraging the value of genomic data in structure-based drug design processes,” John Chiplin, CEO of GeneFormatics, said in a statement.

Earlier in the month, GeneFormatics raised $22 million in its third round of financing.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.